Literature DB >> 8018043

Incidence and prevalence of Huntington's disease in Olmsted County, Minnesota (1950 through 1989).

E Kokmen1, F S Ozekmekçi, C M Beard, P C O'Brien, L T Kurland.   

Abstract

OBJECTIVE: To calculate average annual incidence rates for Huntington's disease (HD) from 1950 through 1989 and to estimate prevalence rates of the disease for January 1, 1960, and January 1, 1990.
DESIGN: Health care records from all sources, including hospitals, outpatient clinics, and long-term care institutions, are readily available for all inhabitants of Olmsted County, Minnesota. The diagnoses entered in these records have been coded and indexed. All health care records containing a diagnosis that might suggest HD were reviewed, and those patients for whom the symptoms of HD began between January 1, 1950, and December 31, 1989, were identified. We used specific criteria for diagnosing HD. PARTICIPANTS: Health care records were reviewed; residence in Olmsted County during the year of symptom onset was required. MAIN OUTCOME MEASURES: Average annual incidence rates and prevalence rates for January 1, 1960, and January 1, 1990.
RESULTS: Overall incidence rates were 0.4 (95% confidence interval [CI], 0.1 to 0.8) for women and 0.2 (95% CI, 0.04 to 0.6) for men per 100,000 person-years. Estimated prevalence rates for January 1, 1960, per 100,000 person-years were 6 (95% CI, 0.7 to 21.5) for women and 6.6 (95% CI, 0.8 to 23.8) for men. For January 1, 1990, the prevalence rates were 1.8 (95% CI, 0.04 to 10.2) for women and 2 (95% CI, 0.05 to 10.9) for men.
CONCLUSIONS: Incidence and prevalence rates of HD in this community are similar to those reported in other communities. The small numbers of affected persons do not allow an estimate of variation over time.

Entities:  

Mesh:

Year:  1994        PMID: 8018043     DOI: 10.1001/archneur.1994.00540190076018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

1.  Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.

Authors:  M A Ramos-Arroyo; S Moreno; A Valiente
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

Review 2.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 3.  Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders.

Authors:  Katherine A Kitchen Andren; Nicolette M Gabel; Julija Stelmokas; Alyson M Rich; Linas A Bieliauskas
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

4.  Huntington's disease in the United States: Variation by demographic and socioeconomic factors.

Authors:  Emilie Bruzelius; Joseph Scarpa; Yiyi Zhao; Sanjay Basu; James H Faghmous; Aaron Baum
Journal:  Mov Disord       Date:  2019-03-13       Impact factor: 10.338

5.  Autoimmune chorea in adults.

Authors:  Orna O'Toole; Vanda A Lennon; J Eric Ahlskog; Joseph Y Matsumoto; Sean J Pittock; James Bower; Robert Fealey; Daniel H Lachance; Andrew McKeon
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

6.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

Authors:  Daniel G Healy; Mario Falchi; Sean S O'Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; Alexis Brice; Jan Aasly; Cyrus P Zabetian; Stefano Goldwurm; Joaquim J Ferreira; Eduardo Tolosa; Denise M Kay; Christine Klein; David R Williams; Connie Marras; Anthony E Lang; Zbigniew K Wszolek; Jose Berciano; Anthony H V Schapira; Timothy Lynch; Kailash P Bhatia; Thomas Gasser; Andrew J Lees; Nicholas W Wood
Journal:  Lancet Neurol       Date:  2008-06-06       Impact factor: 44.182

Review 7.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

8.  Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).

Authors:  Audrey E Hendricks; Jeanne C Latourelle; Kathryn L Lunetta; L Adrienne Cupples; Vanessa Wheeler; Marcy E MacDonald; James F Gusella; Richard H Myers
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

9.  Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease.

Authors:  J Jankovic; J Beach; T Ashizawa
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

10.  Epidemiological survey-based formulae to approximate incidence and prevalence of neurological disorders in the United States: a meta-analysis.

Authors:  Cesar V Borlongan; Jack Burns; Naoki Tajiri; Christine E Stahl; Nathan L Weinbren; Hideki Shojo; Paul R Sanberg; Dwaine F Emerich; Yuji Kaneko; Harry R van Loveren
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.